NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30225% above fair value
$4.82−0.77 (-13.77%)
Close on Nov 18, 2026Market cap $58.59MP/E –Yield –
NutriBand net income
Net income is the profit left for shareholders after every expense, interest and tax.
NutriBand's net income for the twelve months ending Jul 31, 2026 was -$6.96M. For fiscal 2026 it was -$8.23M. The highest annual figure on record is -$151.26K in fiscal 2017.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | -$8.23M | – |
| FY2025 | Jan 31, 2025 | -$10.48M | – |
| FY2024 | Jan 31, 2024 | -$5.49M | – |
| FY2023 | Jan 31, 2023 | -$4.48M | – |
| FY2022 | Jan 31, 2022 | -$6.18M | – |
| FY2021 | Jan 31, 2021 | -$2.93M | – |
| FY2020 | Jan 31, 2020 | -$2.72M | – |
| FY2019 | Jan 31, 2019 | -$3.33M | – |
| FY2018 | Jan 31, 2018 | -$2.67M | – |
| FY2017 | Jan 31, 2017 | -$151.26K | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | -$880.56K | – |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | -$1.24M | – |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | -$968.06K | – |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | -$3.87M | – |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | -$2.00M | – |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | -$1.39M | – |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | -$5.52M | – |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | -$1.36M | – |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | -$1.71M | – |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | -$1.90M | – |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | -$1.88M | – |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$1.76M | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$829.17K | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$1.02M | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$1.68M | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$1.08M | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$1.04M | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$689.99K | – |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$3.77M | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$315.96K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$2.25M | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -$42.57K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$225.87K | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$412.19K | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$944.44K | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$753.27K | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -$450.57K | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -$573.35K | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -$515.75K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$488.62K | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | -$1.88M | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | -$448.10K | – |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | -$2.44M | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | -$107.73K | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | -$92.96K | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | -$35.62K | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | -$33.58K | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | -$29.98K | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | -$35.62K | – |
See a number that looks wrong?